Xencor Inc's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2026 to a ratio of 5.41, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the third quarter 2026. Average receivable collection period, for the Xencor Inc in Sep 30 2026 quarter, has decreased to 67 days, compared to 91 days, in the Jun 30 2026 quarter.

If we take a look into Healthcare sector 458 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2026 from 2985 to 3152.

What is Receivable Turnover Ratio?
What is Xencor Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

XNCR Receivables Turnover Ratio	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Receivable Change	197.35 %	-11.19 %	-68.24 %	-51.85 %	-15.72 %
Y / Y Revenue Change	454.88 %	17.46 %	-86.2 %	-46.51 %	18 %
Receivable Turnover Ratio (TTM)	5.41	3.99	3.52	3.68	3.57
XNCR's Total Ranking	# 3152	# 2985	# 2701	# 2812	#
Accounts Receivable average collection period days	68	92	104	99	102
Seq. Receivable Change	53.52 %	251.92 %	-59.04 %	34.37 %	-54.15 %
Seq. Revenue Change	127.48 %	1034.21 %	-84.01 %	34.47 %	-51.85 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 150
Healthcare Sector	# 459
Overall Market	# 3152

Receivable Turnover Ratio Statistics
High	Average	Low
0.42	0.19	0.07
(Mar 31 2022)		(Jun 30 2015)

XNCR Company Profile • Back to XNCR Efficiency Comparisons • Compare XNCR Receivables Turnover Ratio to its Competitors

Financial Statements
Xencor Inc's Accounts Receivable	$ 65 Millions	Visit XNCR's Balance sheet
Xencor Inc's Sales TTM	$ 200 Millions	Visit XNCR's Income Statement
Sources of XNCR's Revenues		Visit XNCR's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
XNCR's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
XNCR's Growth Rates	XNCR's Roa	XNCR's Inventory Turnover Ratio	XNCR's Dividend Comparisons
XNCR's Profitability Ratios	XNCR's Roi	XNCR's Asset Turnover Ratio	XNCR's Dividend Growth
XNCR's Valuation Ratios	XNCR's Roe	XNCR's Financial Strength Ratios	XNCR's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2026	Receivable at quarter ending Sep 30 2026
Brightspring Health Services Inc	8.50	$ 9,479.144 Millions	$ 1,114.763 Millions
Sotera Health Company	8.49	$ 1,230.250 Millions	$ 144.974 Millions
Tactile Systems Technology Inc	8.23	$ 357.176 Millions	$ 43.385 Millions
Penumbra Inc	8.22	$ 1,560.334 Millions	$ 189.735 Millions
Inspire Medical Systems inc	8.15	$ 882.194 Millions	$ 108.207 Millions
Adapthealth Corp	8.14	$ 3,152.043 Millions	$ 387.280 Millions
Rhythm Pharmaceuticals Inc	8.03	$ 280.748 Millions	$ 34.950 Millions
Alphatec Holdings Inc	7.91	$ 839.652 Millions	$ 106.153 Millions
Exelixis Inc	7.89	$ 2,496.861 Millions	$ 316.636 Millions
Henry Schein Inc	7.84	$ 13,734.000 Millions	$ 1,752.000 Millions
Idexx Laboratories Inc	7.78	$ 4,663.675 Millions	$ 599.701 Millions
Madrigal Pharmaceuticals Inc	7.70	$ 1,427.940 Millions	$ 185.380 Millions
Pulmonx Corporation	7.56	$ 89.176 Millions	$ 11.791 Millions
Merit Medical Systems Inc	7.53	$ 1,612.236 Millions	$ 214.065 Millions
Cerus Corporation	7.48	$ 226.798 Millions	$ 30.308 Millions
Insmed Inc	7.45	$ 1,479.040 Millions	$ 198.502 Millions
Novocure Limited	7.44	$ 725.388 Millions	$ 97.525 Millions
Intuitive Surgical Inc	7.44	$ 12,115.600 Millions	$ 1,629.350 Millions
Quest Diagnostics Inc	7.43	$ 11,841.000 Millions	$ 1,593.250 Millions
Travere Therapeutics Inc	7.32	$ 651.034 Millions	$ 88.900 Millions
Si bone inc	7.19	$ 222.189 Millions	$ 30.881 Millions
Aurinia Pharmaceuticals Inc	7.18	$ 321.738 Millions	$ 44.795 Millions
Beta Bionics Inc	7.15	$ 127.899 Millions	$ 17.897 Millions
Tarsus Pharmaceuticals Inc	7.15	$ 682.203 Millions	$ 95.466 Millions
Angiodynamics Inc	7.13	$ 323.784 Millions	$ 45.418 Millions
Stryker Corp	6.99	$ 26,300.000 Millions	$ 3,761.500 Millions
Boston Scientific Corporation	6.96	$ 21,070.000 Millions	$ 3,028.750 Millions
Syndax Pharmaceuticals Inc	6.89	$ 289.431 Millions	$ 42.011 Millions
Hca Healthcare Inc	6.85	$ 78,701.000 Millions	$ 11,495.250 Millions
Ceribell Inc	6.77	$ 109.203 Millions	$ 16.138 Millions

Date modified: 2026-11-05T09:18:09+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.